Clinical Trial

Phase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumors

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This Study is a single arm, open label, multicenter phase III clinical trial to evaluate the safety and efficacy of VC004 in patients with locally advanced/metastatic solid tumors.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-10-24; most recent amendment 2026-07-23.
Status change: Not Yet Recruiting → Recruiting 2025-03-18
Trial Details
NCT Number NCT06658353
Lead Sponsor Jiangsu vcare pharmaceutical technology co., LTD
Conditions Locally Advanced Solid Tumor
Enrollment 54 participants
Start Date 2025-03-17
Primary Completion 2026-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-27